Medicinal Chemistry PhD Programme (MedChemTrain)

The Medicinal Chemistry PhD Programme (MedChemTrain) is designed to train the next generation of scientists to work at the interface between chemistry and biology at various stages of pre-clinical drug discovery.

It involves the Universities of Coimbra (UCoimbra) and Lisboa (ULisboa), in consortium with Bial, Bluepharma and Hovione.  Both universities, which currently award the PhD degrees that will anchor the MedChemTrain program, are internationally recognized institutions hosting some of the largest and most reputed schools of science and technology in Portugal, such as the Faculty of Sciences and Technology and the Faculty of Pharmacy at UCoimbra, as well as the Faculty of Pharmacy and Instituto Superior Técnico at ULisboa.

This joint initiative is supported by five research units, the Coimbra Chemistry Center and Center for Neuroscience and Cell Biology at UCoimbra, and the Research Institute for Medicines (iMed.ULisboa), Centro de Química Estrutural and Instituto de Medicina Molecular at ULisboa.